Table 3.
Intervention | All Episodes (n = 103) | PIV (n = 48) | RSV (n = 33) | MPV (n = 22) |
---|---|---|---|---|
Ribavirin+IVIGa, n (%) | 39 (37.9) | 3 (6.3) | 20 (60.6) | 16 (72.7) |
IVIG, n (%) | 24 (23.3) | 19 (39.6) | 3 (9.1) | 2 (9.1) |
None, n (%) | 40 (38.8) | 26 (54.2) | 10 (30.3) | 4 (18.2) |
Abbreviations: IVIG, intravenous immunoglobulin; MPV, human metapneumovirus; PIV, parainfluenza virus; RSV, respiratory syncytial virus.
aOne patient additionally received palivizumab, 2 patients did not receive IVIG.